Specialty Drugs in Breast Cancer: Health Care Utilization and Costs in the First Year after Diagnosis
This AARP Public Policy Institute analysis of insurance claims data shows that breast cancer patients taking specialty drugs often incur substantial medical costs in addition to the costs specifically associated with the specialty drugs themselves.
Breast cancer patients ages 50 and older who used specialty drugs to treat their condition faced $120,000 in health care costs, on average, in the first year after diagnosis. Roughly 90 percent of these costs were driven by utilization of both inpatient and outpatient services, rather than the specialty drugs themselves.
Search PPI
Find the Public Policy Institute content you are looking for by entering in search terms below.
Long-Term Services & Supports State Scorecard
A State Scorecard on Long-Term Services and Supports for Older Adults, People with Physical Disabilities, and Family Caregivers
Aging Demographics
One in Three Americans is Now 50 or Older
By 2030, one out of every five people in the United State will be 65-plus. Will your community be ready?
Visit us at www.aarp.org/livable